Safraj Shahul Hameed

Jun 13, 2024 | nature.com | Calum Macdonald |Norah E Palmateer |Laura Lindsay |Safraj Shahul Hameed |Karen Jeffrey |Luke Daines | +9 more

AbstractSeveral population-level studies have described individual clinical risk factors associated with suboptimal antibody responses following COVID-19 vaccination, but none have examined multimorbidity. Others have shown that suboptimal post-vaccination responses offer reduced protection to subsequent SARS-CoV-2 infection; however, the level of protection from COVID-19 hospitalisation/death remains unconfirmed.

Jun 13, 2024 | nature.com | Calum Macdonald |Norah E Palmateer |Laura Lindsay |Safraj Shahul Hameed |Karen Jeffrey |Luke Daines | +9 more

AbstractSeveral population-level studies have described individual clinical risk factors associated with suboptimal antibody responses following COVID-19 vaccination, but none have examined multimorbidity. Others have shown that suboptimal post-vaccination responses offer reduced protection to subsequent SARS-CoV-2 infection; however, the level of protection from COVID-19 hospitalisation/death remains unconfirmed.